North America Microarray Market Overview
The North America Microarray Market is anticipated to reach USD 0.48 Billion by 2030 at 7.3% CAGR during the forecast period 2022-2030. North America the market for Microarray is increasing rapidly. A microarray is a multiplex lab-on-a-chip. It is a 2D array on a solid substrate, usually a glass slide or silicon thin-film cell, that assays large amounts of biological material using high-throughput screening miniaturized, multiplexed and parallel processing and detection methods. Globally the microarray market is dominated by DNA microarrays. The protein microarray is currently the fastest growing market. The use of peptide and carbohydrate microarrays is expanding. Tissue and cell microarrays are in their infancy stage and are developing slowly because of many complications in the process development.
Key Finding
- The North America microarray market is expected to reach $483.4 Million by 2030.
- Paraffin tissue sections (FFPE) hold the largest share of 54.6% of the North America Tissue Microarray market.
- U.S. holds the largest market share of North America Tissue Microarray market and is anticipated to reach $364.2 million by the end of 2030.
- Immunohistochemistry segment holds the largest market share of 47.5% in 2015.
North America Microarray Market Segment Insights
North America Microarray market has been segmented on the basis of types which comprises of protein microarray, tissue microarray, and cellular microarray.
On the basis of product, North America Tissue microarray market is segmented into paraffin tissue sections (FFPE), frozen tissue sections, and others.
On the basis of applications, tissue microarray market is segmented into immunohistochemistry, in-situ hybridization, and others.
Regional Analysis
In North America, U.S. is the largest market for Tissue Microarray. Canada is the second-largest market and is expected to be fastest growing market for Tissue Microarray in North America.
Key Players for North America Microarray Market
Some of the key players in this North America Microarray Market are:
- ABCAM,
- ASTERAND BIOSCIENCE,
- IHC WORLD LLC,
- NOVUS BIOLOGICALS LLC (ACQUIRED BY BIO-TECHNE),
- ORIGENE TECHNOLOGIES INC,
- PANTOMICS, INC,
- PROTEIN BIOTECHNOLOGIES INC,
- US BIOMAX, INC.,
- US BIOUPTON INT,
- VITROVIVO BIOTECH, LLC and
- others.
North America Microarray Market by Application
Study objectives of Microarray Market:
- To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the Microarray market
- To provide insights about factors affecting the market growth
- To analyze the tattoo removal market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
- To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
- To provide country level analysis of the market with respect to the current market size and future prospective
- To provide country level analysis of the market for segments by type, by industry and its sub-segments.
- To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
- To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the North America microarray market.
Intended Audience
- Contract Research Organizations (CROs)
- Research and Development (R&D) Companies
- Government Research Laboratories
- Independent Research Laboratories
- Government and Independent Regulatory Authorities
- Academic Institutes and Universities
The report for North America Microarray Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions
Report Attribute/Metric
|
Details
|
Market Size
|
0.48 billion
|
CAGR
|
7.3%
|
Base Year
|
2021
|
Forecast Period
|
2022-2030
|
Historical Data
|
2020
|
Forecast Units
|
Value (USD Billion)
|
Report Coverage
|
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
|
Segments Covered
|
type, application
|
Geographies Covered
|
U.S. and Canada
|
Key Vendors
|
ABCAM, ASTERAND BIOSCIENCE, IHC WORLD LLC, NOVUS BIOLOGICALS LLC (ACQUIRED BY BIO-TECHNE), ORIGENE TECHNOLOGIES INC, PANTOMICS, INC, PROTEIN BIOTECHNOLOGIES INC, US BIOMAX, INC., US BIOUPTON INT, VITROVIVO BIOTECH
|
Key Market Opportunities
|
Joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments
|
Key Market Drivers
|
technological advancement, macro economical and governing factors
|
North America Microarray Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report